Lexeo Therapeutics, Inc. (LXEO)
5.755
-0.62
(-9.80%)
USD |
NASDAQ |
Mar 18, 16:00
5.72
-0.04
(-0.61%)
Pre-Market: 08:26
Lexeo Therapeutics EPS Diluted (Quarterly) : -0.3326 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Johnson & Johnson | 2.098 |
| Insmed, Inc. | -1.538 |
| Eli Lilly & Co. | 7.024 |
| Madrigal Pharmaceuticals, Inc. | -2.566 |
| Phathom Pharmaceuticals, Inc. | -0.2865 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -20.28M |
| Total Expenses (Quarterly) | 20.28M |
| Enterprise Value | 76.71M |
| Earnings Yield | -46.95% |
| Normalized Earnings Yield | -46.94 |